[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Instructions for Authors::
Instructions for Reviewers::
Checklists::
Articles archive::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 7, Issue 1 (5-2023) ::
jhgg 2023, 7(1): 0-0 Back to browse issues page
Highly efficient ESC genome editing with CRISPR/Cas9 for production of laboratory models
Mansoureh Ajami , Omid Moeini , Amir Atashi , Masoud Soleimani , Hossein Dehghani , Monireh Ajami *
Abstract:   (308 Views)
Background: Beta-thalassemia is a group of hereditary blood disorders caused by mutations in the β-globin gene cluster resulting in variable phenotypes ranging from severe anemia to clinically asymptomatic individuals. This study aimed to produce an in vitro model of β-thalassemia using CRISPR/Cas9 as an easily programmable, fast, more powerful, and efficient technique.
Materials and Methods: Guide RNA (gRNA)-Cas9 co-expression vectors were used for embryonic stem (ES) cell nucleofection. PCR, T7EI, and Hbb-b1 gene sequencing tests were done on extracted DNA to evaluate gene mutation. Following erythroid differentiation of ES cells, analysis of hemoglobin genes and erythroid transcription factors were assessed using a quantitative reverse transcription-polymerase chain reaction.
Results: Sequencing data associated with clone 31 confirmed the deletion of 851 nucleotides between exon 2 and 3 in an Hbb-b1 allele in this clone and Indel mutation in exon 2 (-40bp/+38bp) from another allele of Hbb-b1. Significant expression of erythroid transcription factors was observed in wild type, Hbb-b1+/- and Hbb-b1-/- groups. The hbb-b1 gene expression in the Hbb-b1+/- group significantly decreased, although the Hbb-b1-/- group had zero expression.
Conclusion: Utilizing an efficient erythroid differentiation method on the CRISPR/Cas9-mediated Hbb-b1 knock-out in ES cells provides accessibility to the laboratory thalassemia model. This method could be used to produce a mouse model of β-thalassemia intermedia (Hbbth1/th1 mice), which are required for the identification of the molecular basis of β-thalassemia and enable testing of the therapeutic approaches such as the recovery of functional β or γ hemoglobin chain.
Keywords:  Beta‐thalassemia, CRISPR‐Cas9 system, Hbb‐b1, Mouse embryonic stem cell
Full-Text [PDF 952 kb]   (31 Downloads)    
Type of Study: Research | Subject: Gene expression
Received: 2023/03/15 | Accepted: 2023/05/20 | Published: 2023/05/20
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.TMU.REC.1394.236



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ajami M, Moeini O, Atashi A, Soleimani M, Dehghani H, Ajami M. Highly efficient ESC genome editing with CRISPR/Cas9 for production of laboratory models. jhgg 2023; 7 (1)
URL: http://humangeneticsgenomics.ir/article-1-87-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 1 (5-2023) Back to browse issues page
Journal of Human Genetics and Genomics Journal of Human Genetics and Genomics
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645